P. Freitag

发表

Effect of eye movements on the magnitude of functional magnetic resonance imaging responses in extrastriate cortex during visual motion perception

K. Scheffler, M. Greenlee, M. Greenlee, 1998, Experimental Brain Research.

Atrophy is detectable within a 3-month period in untreated patients with active relapsing remitting multiple sclerosis.

Ludwig Kappos, Stefan Wagenpfeil, Martin Hardmeier, 2003, Archives of neurology.

Locoregional regulatory peptide receptor targeting with the diffusible somatostatin analogue 90Y-labeled DOTA0-D-Phe1-Tyr3-octreotide (DOTATOC): a pilot study in human gliomas.

O. Gratzl, A. Merlo, J. Reubi, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Locoregional Regulatory Peptide Receptor Targeting with the Diffusible Somatostatin Analogue 90 Y-Labeled

O. Gratzl, A. Merlo, J. Reubi, 1999 .

Local injection of the 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: an extended pilot study

O. Gratzl, S. Hofer, A. Merlo, 2002, European Journal of Nuclear Medicine and Molecular Imaging.

The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis.

L. Kappos, R. Lindberg, D. Leppert, 2001, Brain : a journal of neurology.

Successful diffusible brachytherapy (dBT) of a progressive low-grade astrocytoma using the locally injected peptidic vector and somatostatin analogue [90Y]-DOTA0-D-Phe1-Tyr3-octreotide (DOTATOC).

S. Hofer, A. Merlo, J. Reubi, 2001, Swiss medical weekly.

fMRI Response During Visual Motion Stimulation in Patients with Late Whiplash Syndrome

M. Greenlee, M. Greenlee, E. Radue, 2001, Neurorehabilitation and neural repair.

PET imaging drug distribution after intratumoral injection: the case for (124)I-iododeoxyuridine in malignant gliomas.

R. P. Maguire, O. Gratzl, J. Missimer, 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Rate of brain atrophy in relapsing MS decreases during treatment with IFNβ-1a

E. Radue, R. Rudick, E. Fisher, 2005, Neurology.

Motor, somatosensory and auditory cortex localization by fMRI and MEG

K Scheffler, J Kassubek, D Bilecen, 1998, Neuroreport.

Image registration and subtraction to detect active T2 lesions in MS: an interobserver study

Massimo Filippi, Frederik Barkhof, Franz Fazekas, 2002, Journal of Neurology.

Increase in serum levels of uric acid, an endogenous antioxidant, under treatment with glatiramer acetate for multiple sclerosis

L. Kappos, C. Constantinescu, P. Freitag, 2000, Multiple sclerosis.

A randomized, double-blind, placebo-controlled study of oral hydrolytic enzymes in relapsing multiple sclerosis

L. Kappos, M. Daumer, P. Freitag, 2005, Multiple sclerosis.